CN100393694C - 四苄基伏格列波糖的结晶及制备方法 - Google Patents
四苄基伏格列波糖的结晶及制备方法 Download PDFInfo
- Publication number
- CN100393694C CN100393694C CNB2006100617134A CN200610061713A CN100393694C CN 100393694 C CN100393694 C CN 100393694C CN B2006100617134 A CNB2006100617134 A CN B2006100617134A CN 200610061713 A CN200610061713 A CN 200610061713A CN 100393694 C CN100393694 C CN 100393694C
- Authority
- CN
- China
- Prior art keywords
- preparation
- voglibose
- tetrabenzyl
- tetrabenzyl voglibose
- atom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/44—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton bound to carbon atoms of the same ring or condensed ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100617134A CN100393694C (zh) | 2006-07-17 | 2006-07-17 | 四苄基伏格列波糖的结晶及制备方法 |
CA002654424A CA2654424A1 (en) | 2006-07-17 | 2007-06-18 | Tetra-benzyl voglibose in crystalline form and a method for preparing the same |
KR1020087031619A KR101379988B1 (ko) | 2006-07-17 | 2007-06-18 | 결정상의 테트라벤질 보글리보스 및 그의 제조방법 |
PCT/CN2007/001902 WO2008011791A1 (fr) | 2006-07-17 | 2007-06-18 | Voglibose tetrabenzyle cristallin et procédé de préparation associé |
JP2009519780A JP5216006B2 (ja) | 2006-07-17 | 2007-06-18 | 結晶型テトラベンジルボグリボース及びその製造方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100617134A CN100393694C (zh) | 2006-07-17 | 2006-07-17 | 四苄基伏格列波糖的结晶及制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1931826A CN1931826A (zh) | 2007-03-21 |
CN100393694C true CN100393694C (zh) | 2008-06-11 |
Family
ID=37877872
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006100617134A Expired - Fee Related CN100393694C (zh) | 2006-07-17 | 2006-07-17 | 四苄基伏格列波糖的结晶及制备方法 |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP5216006B2 (ja) |
KR (1) | KR101379988B1 (ja) |
CN (1) | CN100393694C (ja) |
CA (1) | CA2654424A1 (ja) |
WO (1) | WO2008011791A1 (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100393694C (zh) * | 2006-07-17 | 2008-06-11 | 深圳市药兴生物科技开发有限公司 | 四苄基伏格列波糖的结晶及制备方法 |
US10211049B2 (en) * | 2015-08-07 | 2019-02-19 | North Carolina State University | Synthesis and processing of pure and NV nanodiamonds and other nanostructures |
CN105254514B (zh) * | 2015-11-12 | 2017-09-05 | 重庆植恩药业有限公司 | 一种四苄基伏格列波糖的制备方法 |
CN110317142B (zh) * | 2019-07-18 | 2023-03-28 | 植恩生物技术股份有限公司 | 一种伏格列波糖的制备方法 |
CN113214094A (zh) * | 2021-04-26 | 2021-08-06 | 潍坊天福化学科技有限公司 | 一种伏格列波糖的合成方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005030698A1 (en) * | 2003-09-26 | 2005-04-07 | Ranbaxy Laboratories Limited | Process for the preparation of voglibose |
WO2005049574A1 (en) * | 2003-11-20 | 2005-06-02 | Warner-Lambert Company Llc | Androgen receptor modulators |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61205455A (ja) * | 1985-03-11 | 1986-09-11 | Takeda Chem Ind Ltd | 低カロリ−砂糖含有組成物 |
JP2001058944A (ja) * | 1999-06-18 | 2001-03-06 | Takeda Chem Ind Ltd | 速崩壊性固形製剤 |
JP2003034655A (ja) * | 2001-05-15 | 2003-02-07 | Takeda Chem Ind Ltd | 速崩壊性固形製剤 |
JP4408340B2 (ja) * | 2002-03-22 | 2010-02-03 | 武田薬品工業株式会社 | 速崩壊性固形製剤 |
WO2005049547A1 (en) | 2003-11-21 | 2005-06-02 | Ranbaxy Laboratories Limited | Process for the preparation of 1,2,3,4-cyclohexanetetrol derivatives |
CN100393694C (zh) * | 2006-07-17 | 2008-06-11 | 深圳市药兴生物科技开发有限公司 | 四苄基伏格列波糖的结晶及制备方法 |
-
2006
- 2006-07-17 CN CNB2006100617134A patent/CN100393694C/zh not_active Expired - Fee Related
-
2007
- 2007-06-18 WO PCT/CN2007/001902 patent/WO2008011791A1/zh active Application Filing
- 2007-06-18 CA CA002654424A patent/CA2654424A1/en not_active Abandoned
- 2007-06-18 JP JP2009519780A patent/JP5216006B2/ja not_active Expired - Fee Related
- 2007-06-18 KR KR1020087031619A patent/KR101379988B1/ko not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005030698A1 (en) * | 2003-09-26 | 2005-04-07 | Ranbaxy Laboratories Limited | Process for the preparation of voglibose |
WO2005049574A1 (en) * | 2003-11-20 | 2005-06-02 | Warner-Lambert Company Llc | Androgen receptor modulators |
Also Published As
Publication number | Publication date |
---|---|
WO2008011791A1 (fr) | 2008-01-31 |
JP5216006B2 (ja) | 2013-06-19 |
KR101379988B1 (ko) | 2014-04-01 |
CN1931826A (zh) | 2007-03-21 |
JP2009543814A (ja) | 2009-12-10 |
CA2654424A1 (en) | 2008-01-31 |
KR20090031376A (ko) | 2009-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112876454A (zh) | 一种人工合成(r,s)-尼古丁盐的制备方法 | |
CN100393694C (zh) | 四苄基伏格列波糖的结晶及制备方法 | |
CN101863948B (zh) | 高纯度(2β,3α,5α,16β,17β)-2-(4-吗啉基)-16-(1-吡咯烷基)-雄甾烷-3,17-二醇或其组合物及其制备方法 | |
EP2807143A2 (en) | Process for preparation of fingolimod | |
CN103242193B (zh) | 一种羟肟化杯[6]芳烃高效铀萃取剂的制备及其用途 | |
CN101289439B (zh) | 一种制备阿拉伯烯糖的方法 | |
CN105254569A (zh) | 奥硝唑注射液杂质1-(3-氯-丙烯基)-2-甲基-5-硝基咪唑的制备方法 | |
CN101279925B (zh) | 四苄基伏格列波糖盐及其制备方法和应用 | |
CN103073446B (zh) | 盐酸伊托必利的制备方法 | |
CN114539077B (zh) | 一种盐酸左沙丁胺醇的合成方法 | |
CN104961787B (zh) | 一种虫草素的合成方法 | |
CN109912512B (zh) | 一种新的替米沙坦杂质化合物及其制备方法和用途 | |
CN107715909B (zh) | 一种季戊四醇支载的脯氨酸催化剂及其制备方法及应用 | |
CN106083689B (zh) | 一种赛洛多辛化合物的制备方法 | |
CN105884625B (zh) | 一种r-沙美特罗的合成方法 | |
CN110804022B (zh) | 一种右丙亚胺的制备方法 | |
CN106957235B (zh) | 一种他莫昔芬的制备方法 | |
CN102260236B (zh) | 一种香豆素类化合物的制备方法 | |
CN105130841A (zh) | 一种3-碘苯基叠氮化合物的制备方法 | |
CN114605241B (zh) | 一种盐酸艾司氯胺酮中间体的制备方法及其中间体 | |
CN106146424A (zh) | 一种5-甲基-3,4-二苯基异噁唑的制备方法 | |
CN108530375B (zh) | 4-氧杂-7-氮杂螺[2.5]辛烷或其盐的中间体及制备方法 | |
CN110105371B (zh) | 一种多拉达唑原料药中的杂质及其制备方法 | |
CN103387574A (zh) | 一种表小檗碱的合成方法 | |
US20170233334A1 (en) | Method for preparing d-arginine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20081205 Address after: Jiangsu city of Wuxi province Jiangyin Qingyang China Zhen Min Pu Lu No. 9 Patentee after: Pharmaxyn Lab Ltd. Address before: Guangdong Province, Shenzhen City, Nanshan District South Road Nanyuan Village East Room 3-101 Patentee before: Yaoxing Biological Sci-Tech Development Co., Ltd., Shenzhen |
|
ASS | Succession or assignment of patent right |
Owner name: WUXI YAOXING PHARMACEUTICAL TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: SHENZHEN CITY YAOXING BIOLOGICAL TECHNOLOGY DEVELOPMENT CO., LTD. Effective date: 20081205 |
|
C35 | Partial or whole invalidation of patent or utility model | ||
IW01 | Full invalidation of patent right |
Decision date of declaring invalidation: 20090831 Decision number of declaring invalidation: 13740 Granted publication date: 20080611 |
|
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080611 Termination date: 20110717 |